EHTH NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

eHealth Inc · Financial Services · Insurance Brokers

Open interactive chart View report data
Latest close 1.33 USD
-0.7% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -28.5% below the Trend Line and sits at 2.8% of its 52-week range. The latest completed week returned -0.7%, after a -16.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 25/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 14 out of 100
Latest Close 1.33 USD 31 Jul 2026
1W Return -0.7% latest completed week
4W Return -16.9% short-term follow-through
12W Return -29.6% quarterly tape
Trend Breadth 7.7% 4 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.7% Latest completed week; four-week move -16.9%. Indicator stack 4/40 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.66% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 25/100 conviction; expected move 86.8%. News sentiment 47/100 52 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -28.5% below the Trend Line and sits at 2.8% of its 52-week range. The latest completed week returned -0.7%, after a -16.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -16.9% over four weeks, -29.6% over 12 weeks, and -58.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-0.7%
4W-16.9%
12W-29.6%
26W-53.0%
52W-58.6%
Active trend streak0 weeks
Active weeks in one year4
Trend breadth7.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.05Latest activity-pressure read.
Pressure change-110.9%Four-week change in activity pressure.
Leadership-57.77Latest relative-leadership reading.
RS change-6.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength27/100Blend of value, momentum, and quality. Underlying universe rank 74; rank 1 is best.
Value40/100Relative valuation strength. Underlying universe rank 61; rank 1 is best.
Quality38/100Profitability and accounting quality. Underlying universe rank 63; rank 1 is best.
Momentum40/100Medium-term price momentum. Underlying universe rank 61; rank 1 is best.
Growth40/100Revenue and earnings growth. Underlying universe rank 61; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
1.3x
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
1.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-53.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
98.8%
Gross profit retained from each unit of revenue.
Operating margin
11.5%
Operating profit retained from revenue.
Free-cash-flow margin
-10.2%
Free cash flow generated from revenue.
Return on invested capital
4.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-4.3%
Latest one-year revenue growth.
EPS growth
15.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-3111.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
13.9%
Cash dividends relative to market value.
Buyback yield
4.5%
Net share repurchases relative to market value.
Shareholder yield
18.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

EHTH shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 86.8%, and Sharemaestro trend signal inactive.

Conviction25/100
Expected move86.8%
Put/call volume
Pressure12
Speculation0
Volatility96
Trend agreement40
Open options detail
Insider activity7 / 9

7 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment47/100

Weighted news tone is neutral across 52 relevant articles.

9 positive · 32 neutral · 11 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move86.8%Nearest-chain priced movement where available.
52-week drawdown-77.4%Distance below the 52-week high.
13-week volatility6.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+39.4%Week of 17 Apr.
Worst week-23.4%Week of 13 Feb.
Latest week-0.7%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains2
Flat weeks0
Modest losses3
Sharp losses14
Recent vol6.7%13-week weekly-return volatility.
Base vol11.5%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew10.5% / -7.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape16/100

Trend, activity pressure, participation, and risk combine to a 16/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Next-Week ExpectancyNegative 43.66%

Next-week expectancy is negative with a 43.66% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 83; Buyback Yield rank 13 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options40/100

EHTH shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 86.8%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 86.8% Sentiment47/100

Weighted news tone is neutral across 52 relevant articles.

eHealth Inc expected to post a loss of 71 cents a share - Earnings Preview Insiders7 / 9

7 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.33 USD-0.7%1.86 USD5.10 USD-0.05-57.77832.0KOff
24 Jul 20261.34 USD-10.1%1.96 USD5.15 USD0.16-57.911.0MOff
17 Jul 20261.49 USD-8.0%2.05 USD5.19 USD0.46-54.851.1MOff
10 Jul 20261.62 USD1.3%2.15 USD5.23 USD0.51-53.792.2MOff
3 Jul 20261.60 USD5.3%2.24 USD5.27 USD0.46-54.412.1MOff
26 Jun 20261.52 USD-7.9%2.32 USD5.31 USD0.49-57.194.9MOff
19 Jun 20261.65 USD-8.8%2.40 USD5.35 USD0.40-56.54821.3KOff
12 Jun 20261.81 USD4.6%2.46 USD5.39 USD0.44-52.021.5MOff
5 Jun 20261.73 USD11.6%2.53 USD5.44 USD0.43-53.972.6MOff
29 May 20261.55 USD-1.9%2.61 USD5.49 USD0.36-61.411.7MOff
22 May 20261.58 USD-10.2%2.73 USD5.53 USD0.33-60.341.3MOff
15 May 20261.76 USD-6.9%2.85 USD5.56 USD0.19-56.251.3MOff
8 May 20261.89 USD-7.4%2.95 USD5.60 USD0.01-54.112.1MOff
1 May 20262.04 USD7.9%3.04 USD5.64 USD-0.39-49.082.5MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.